No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: Results from the factors influencing the Barrett's adenocarcinoma relationship case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 736-739

  Ferguson, Heather R ^a   Wild, Christopher P ^d   Anderson, Lesley A ^b   Murphy, Seamus J ^e   Johnston, Brian T ^c   Murray, Liam J ^b   Watson, R G Peter ^c   McGuigan, Jim ^c   Reynolds, John V ^f   Hardie, Laura J ^d  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e DAISY HILL HOSPITAL   (United Kingdom)

^f ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTINE; ENZYME; GENOMIC DNA; HOGG1 ENZYME; LYSINE; SERINE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; DNA REPAIR; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; FEMALE; GENOTYPE; HUMANS; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 41549138366     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2832     Document Type: Article

References (14)

1. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53:1070-4.
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
3. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127-41.
4. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
5. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005;161:1-14.
6. Hill JW, Evans MK. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res 2006;34:1620-32.
7. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
8. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001;61:1354-7.
9. Liu G, Zhou W, Yeap BY, et al. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis 2007;28:1254-8.
10. 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis 2006;27:1835-41.
11. Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005;26:1536-41.
12. Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia- adenocarcinoma sequence. Cancer Res 2006;66:4975-82.
13. 326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001;95:140-3.
14. Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004;64:4378-84.